SCHEMBL3838445

SCHEMBL3838445

C=C(CC)C(=O)OCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57345 0.82 THRB (0.50)
SCHEMBL35720 0.82
SCHEMBL5297552 0.81 ALDH1A1 (0.37)
SCHEMBL1093533 0.80
Methyl Alcohol SCHEMBL29084611 0.80 ALDH1A1 (0.50)
SCHEMBL27491399 0.80
SCHEMBL1923846 0.78 ALDH1A1 (0.37)
SCHEMBL3478021 0.78 TSHR (0.45)
SCHEMBL21633996 0.78
SCHEMBL3357134 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107325101-B The synthetic method of 6- methylol -6,7- dihydro -5H, 9H- imidazo diazepine -8- carboxylic acid tert-butyl ester 上海合全药物研发有限公司 2019-03-26 CN claimed
CN-107325101-A The synthetic method of the carboxylic acid tert-butyl ester of 6 methylol, 6,7 dihydro 5H, 9H imidazo diazepine 8 上海合全药物研发有限公司 2017-11-07 CN claimed
US-6750223-B2 TO INHIBIT THE GROWTH OF A VARIETY OF TUMOR/CANCER CELLS, ESPECIALLY LEUKEMIA, COLON, MELANOMA, AND BREAST CANCER CELLS KAOHSIUNG MEDICAL UNIVERSITY (TW) 2004-06-15 US claimed
US-20040072856-A1 4-ANILINO[2,3-b]QUINOLINE DERIVATIVES,THEIR PREPARATION PROCECC ANDPHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME KAOHSIUNG MEDICAL UNIVERSITY (TW) 2004-04-15 US claimed
US-20220402855-A1 PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-22 US disclosed
US-20220402856-A1 PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-22 US disclosed
WO-2021138073-A1 PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE DOW GLOBAL TECHNOLOGIES LLC (US) 2021-07-08 WO disclosed
WO-2021138075-A1 PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE DOW GLOBAL TECHNOLOGIES LLC (US) 2021-07-08 WO disclosed
CN-107108540-B Butyrolactone compound and manufacturing method 日产化学工业株式会社 2019-08-02 CN disclosed
CN-107108463-B The processing method of tin compound in reaction mixture 日产化学工业株式会社 2019-05-17 CN disclosed
CN-107108463-A The processing method of tin compound in reactant mixture 日产化学工业株式会社 2017-08-29 CN disclosed
CN-107108540-A Butyrolactone compound and manufacture method 日产化学工业株式会社 2017-08-29 CN disclosed
EP-1617806-A4 SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS MERCK & CO INC (US) 2006-11-02 EP disclosed
EP-1617806-A2 SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2006-01-25 EP disclosed
WO-2004093805-A2 SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2004-11-04 WO disclosed
US-6630501-B1 Treatment of cancer due to overexpression of enzymes of this family COMMISSARIAT A L'ENERGIE ATOMIQUE 2003-10-07 US disclosed
US-6576684-B1 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-10 US disclosed
EP-1112288-A1 THERMAL- AND PHOTOINITIATED RADICAL POLYMERIZATION IN THE PRESENCE OF AN ADDITION FRAGMENTATION AGENT Ciba SC Holding AG (CH) 2001-07-04 EP disclosed
WO-2000011041-A1 THERMAL- AND PHOTOINITIATED RADICAL POLYMERIZATION IN THE PRESENCE OF AN ADDITION FRAGMENTATION AGENT CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-03-02 WO disclosed
US-5336686-A Glucocorticoid, progesterone and androgen antagonists; hormone inhibitors; antiproliferative activity; antitumor and carcinogenic agents ROUSSEL-UCLAF (FR) 1994-08-09 US disclosed